Dr. Christine Dufès is a Reader (Associate Professor) in Nanomedicine and Director of the Postgraduate School at the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). She teaches on the Master of Pharmacy and on various MSc postgraduate degrees. Christine obtained a Doctorate in Pharmacy (with Distinction and congratulations of the Jury, 1997) and a PhD (with a European Label, Distinction and congratulations of the Jury, 2002) from the University of Poitiers (France). After four years as a post-doctoral researcher at the Cancer Research UK Beatson Laboratories in Glasgow, she was appointed as a Lecturer in SIPBS in 2006. Her research focuses on the development of targeted drug- and gene-based nanomedicines for cancer therapy and brain delivery. It resulted in 2 patents, 54 peer-reviewed publications, 4 book chapters and attracted 4100+ citations (h-index: 32, Google Scholar). All her PhD students (from diverse backgrounds) submitted their theses within the imparted time and are now further developing their careers in either Academia or Industry. Christine has been awarded the Bourse d’Excellence Lavoisier (2002), the Award of the 9th Annual Symposium of the United Kingdom and Ireland Controlled Release Society (2003), the Biochemical Journal Young Investigator Award (2009), the Tom Gibson Memorial Award (2012), the Scientist Medal of the International Association of Advanced Materials (2021) and the Outstanding Woman Researcher in Nanomedicine award at the 7th Venus International Women Awards (2021) for her research. She also received the “Best Overall” Strathclyde Teaching Excellence Award (2013) for her teaching, was nominated 10 times since 2013 and was shortlisted in the category “Best in Faculty of Science” in 2015, 2018 and 2022. She was the only staff member from her department to be nominated for a Strathclyde Teaching Excellence Award by the students in 2020. ​She is an elected Fellow of the Royal Society of Biology, a Fellow of the Higher Education Academy, a Trustee of the British Society of Nanomedicine, Strathclyde Network Lead for the UK Reproducibility Network.